Gufic Biosciences Profile
Key Indicators
- Authorised Capital ₹ 85.75 Cr
as on 29-06-2024
- Paid Up Capital ₹ 10.03 Cr
as on 29-06-2024
- Company Age 40 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 454.62 Cr
as on 29-06-2024
- Satisfied Charges ₹ 201.51 Cr
as on 29-06-2024
- Revenue 59.18%
(FY 2022)
- Profit 116.68%
(FY 2022)
- Ebitda 73.64%
(FY 2022)
- Net Worth 55.17%
(FY 2022)
- Total Assets 32.99%
(FY 2022)
About Gufic Biosciences
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 509079 and on the National Stock Exchange(NSE) under GUFICBIO.
The Corporate was formerly known as Central Leasing Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 85.75 Cr and a paid-up capital of Rs 10.03 Cr.
The company currently has active open charges totaling ₹454.62 Cr. The company has closed loans amounting to ₹201.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Gufic Biosciences Limited India are Ami Shah as Company Secretary, Pranav Choksi as Ceo, and Devkinandan Roonghta as Cfo. Dilip Ghosh, Shrirang Vaidya, Gopal Daptari, and Seven other members serve as directors at the Company.
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Gufic Biosciences?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ami Shah  | Company Secretary | 22-Mar-2016 | Current |
| Pranav Choksi | CEO | 01-Oct-2014 | Current |
| Devkinandan Roonghta | CFO | 29-Oct-2018 | Current |
| Jayesh Choksi | Managing Director | 31-Aug-1999 | Current |
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shrirang Vaidya | Director | 12-Feb-2018 | Current |
| Gopal Daptari | Director | 24-Nov-2016 | Current |
| Rabi Sahoo | Director | 29-Jun-2019 | Current |
Bal Singh  | Director | 29-May-2018 | Current |
| Dilip Ghosh | Whole-Time Director | 12-Nov-2020 | Current |
| Anu Aurora | Director | 23-Dec-2019 | Current |
Financial Performance of Gufic Biosciences.
Gufic Biosciences Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 59.18% increase. The company also saw a substantial improvement in profitability, with a 116.68% increase in profit. The company's net worth Soared by an impressive increase of 55.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gufic Biosciences?
In 2022, Gufic Biosciences had a promoter holding of 75.48% and a public holding of 24.53%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gufic Private LimitedActive 53 years 8 monthsPankaj Gandhi, Pranav Choksi and 1 more are mutual person
- Large & Mid Corporate Financial Services Private LimitedActive 8 years 9 months
Shrirang Vaidya is a mutual person
- Gufic Prime Private LimitedActive 1 year 1 month
Bal Singh, Pankaj Gandhi and 2 more are mutual person
- Vishoushadhi Products And Services Private LimitedActive 5 years 10 months
Bal Singh is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Aug 2023 | ₹1.49 M | Open |
Hdfc Bank Limited Creation Date: 08 Dec 2022 | ₹130.00 Cr | Open |
Others Creation Date: 21 Sep 2022 | ₹17.30 Cr | Open |
How Many Employees Work at Gufic Biosciences?
Gufic Biosciences has a workforce of 1522 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gufic Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gufic Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
